BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 835372)

  • 1. Accumulation of myoinositol in plasma and red cells of diabetic patients.
    Servo C
    Acta Med Scand; 1977 Jan; 201(1-2):59-62. PubMed ID: 835372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorbitol and myoinositol levels in the cerebrospinal fluid of diabetic patients.
    Servo C
    Acta Endocrinol Suppl (Copenh); 1980; 238():133-7. PubMed ID: 6933810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma, red cell and cerebrospinal fluid concentrations of myoinositol in patients with severe chronic renal failure.
    Servo C; Bardy A; Pasternack A; Pitkänen E
    Ann Clin Res; 1976 Dec; 8(6):374-7. PubMed ID: 1008476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoinositol metabolism in diabetes mellitus. Effect of insulin treatment.
    Clements RS; Reynertson R
    Diabetes; 1977 Mar; 26(3):215-21. PubMed ID: 838172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyols in the cerebrospinal fluid and plasma of neurological, diabetic and uraemic patients.
    Servo C; Palo J; Pitkänen E
    Acta Neurol Scand; 1977 Aug; 56(2):111-6. PubMed ID: 899715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in polyol levels in cerebrospinal fluid and serum in diabetic patients.
    Servo C; Pitkänen E
    Diabetologia; 1975 Dec; 11(6):575-80. PubMed ID: 1205026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral supplementation of myoinositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals.
    Gregersen G; Bertelsen B; Harbo H; Larsen E; Andersen JR; Helles A; Schmiegelow M; Christensen JE
    Acta Neurol Scand; 1983 Mar; 67(3):164-72. PubMed ID: 6868954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid sorbitol and myoinositol in diabetic polyneuropathy.
    Servo C; Bergström L; Fogelholm R
    Acta Med Scand; 1977; 202(4):301-4. PubMed ID: 920249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myoinositol--a uremic neurotoxin?
    Blumberg A; Esslen E; Bürgi W
    Nephron; 1978; 21(4):186-91. PubMed ID: 683404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes.
    Greene DA; De Jesus PV; Winegrad AI
    J Clin Invest; 1975 Jun; 55(6):1326-36. PubMed ID: 124320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma myoinositol in diabetics including patients with renal allografts.
    Barbosa J
    Acta Diabetol Lat; 1978; 15(1-2):95-101. PubMed ID: 362783
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormal glomerular filtration rate, renal plasma flow, and renal protein excretion in recent and short-term diabetics.
    Ditzel J; Junker K
    Br Med J; 1972 Apr; 2(5804):13-9. PubMed ID: 5015964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-chiro-inositol metabolism in diabetes mellitus.
    Ostlund RE; McGill JB; Herskowitz I; Kipnis DM; Santiago JV; Sherman WR
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9988-92. PubMed ID: 8234346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral nerve concentrations of glucose, fructose, sorbitol and myoinositol in diabetic and non-diabetic patients.
    Hale PJ; Nattrass M; Silverman SH; Sennit C; Perkins CM; Uden A; Sundkvist G
    Diabetologia; 1987 Jul; 30(7):464-7. PubMed ID: 3666344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal ouabain inhibitable Na-K ATPase activity and myoinositol supplementation in experimental diabetes mellitus.
    Finegold DN; Strychor S
    Metabolism; 1988 Jun; 37(6):557-61. PubMed ID: 2897613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of glucagon on myoinositol levels in the blood serum and its excretion with urine.
    Markiewicz K; Lutz W; Cholewa M
    Acta Physiol Pol; 1978; 29(5):475-9. PubMed ID: 747110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phosphatidylinositol and myoinositol concentration in the erythrocytes and plasma in chronic renal insufficiency].
    Walasek L; Lutz W; Trznadel K
    Pol Tyg Lek; 1979 Jul; 34(27):1065-8. PubMed ID: 514831
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats.
    Yue DK; Hanwell MA; Satchell PM; Handelsman DJ; Turtle JR
    Metabolism; 1984 Dec; 33(12):1119-22. PubMed ID: 6438438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inositol in the cerebrospinal fluid, plasma and erythrocytes in spinal pain syndromes].
    Maciejek Z; Chmielewski H; Lutz W; Niezgodzińska A
    Neurol Neurochir Pol; 1984; 18(2):125-30. PubMed ID: 6237272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group.
    Nelson RG; Bennett PH; Beck GJ; Tan M; Knowler WC; Mitch WE; Hirschman GH; Myers BD
    N Engl J Med; 1996 Nov; 335(22):1636-42. PubMed ID: 8929360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.